newsfilter
← Latest News
GlobeNewswire·

Amryt to Report Q1 2022 Results on May 4, 2022

Amryt to Report Q1 2022 Results on May 4, 2022 DUBLIN, Ireland, and Boston MA, April 14, 2022, Amryt (NASDAQ:AMYT) a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare di